COO  Cooper Companies Inc. (The)

Exchange

NYSE

Sector

Health Care

Industry

Ophthalmic Goods

Market Cap.

8.21B

Vuru Grade

48.79/100

Current Price

$168.39
+2.68 (+1.62%)

Growth Price

$74.24
Overvalued by 55.91%

Company Metrics

  • P/E 32.97
  • P/S 4.24
  • P/B 2.96
  • EPS 5.11
  • Cash ROIC 7.18%
  • Cash Ratio 0.03
  • Dividend 0.06 / 0.04 %
  • Avg. Vol. 680,556.00
  • Shares 48.76M
  • Market Cap. 8.21B

Company Description

The Cooper Companies, Inc., through its subsidiaries, develops, manufactures, and markets healthcare products serving the vision care and women's healthcare markets worldwide. It offers a range of soft contact lenses for the vision care market, such as toric lenses, which correct astigmatism; multifocal lenses for presbyopia; and spherical lenses that correct the common visual defects. The company... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

The Oral History Of The Poop Emoji (Or, How Google Brought Poop To America)
Fast Company - Aug 5, 2013
More than just another location for a global tech company, it reflects what we're working hardest at as we head into 2017, and how we want to get there.
Earnings Coverage: Positive EPS Estimates for Cooper Companies Inc (COO)
MoneyMakingArticles - 10 hours ago
Wall Street await Cooper Companies Inc (NYSE:COO) to release earnings on December, 8 after the close. Analysts forecast EPS of $2.24, up exactly $0.24 or 12.00% from 2014's $2 EPS.
Cooper Companies Inc. (The) (COO) Moves Higher on Volume Spike for December 06 - Equities.com
SEC Filing: As Cooper Cos Inc/The (COO) Market Valuation Rose, Arizona State ... - Chester News
Is Cooper Companies (COO) Poised for Earnings Beat in Q4?
Nasdaq - 7 hours ago
Zacks ESP: Cooper Companies' Earnings ESP stands at +0.45%. This is because the company's Most Accurate estimate is $2.25 while the Zacks Consensus Estimate is pegged at $2.24.
Investor Circle: Watching the Numbers on Shares of The Cooper Companies, Inc ...
Wall Street Lion - 6 hours ago
Traders and investors tracking shares of The Cooper Companies, Inc. (NYSE:COO) may be examining the company's FCF or Free Cash Flow.
Brokerage Firm Target Update on Cooper Companies Inc (NYSE:COO)
AR News - 1 hour ago
During the past trading session, shares of Cooper Companies Inc (NYSE:COO) traded +1.36%. Covering analysts are predicting the stock to move to $197.75 within the next year.
How The Cooper Companies Inc (COO) Stacks Up Against Its Peers
Insider Monkey (blog) - Dec 1, 2016
Hedge funds are not perfect. They have their bad picks just like everyone else. Valeant, a stock hedge funds have loved, lost 79% during the last 12 months ending in November 21.
The Cooper Companies Acquires Assets of Recombine
GlobeNewswire (press release) - May 25, 2016
PLEASANTON, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical has acquired the commercial assets of Recombine Inc., a clinical genetic testing company specializing in carrier ...
Cooper Companies Inc (NYSE:COO) Bearish Target AT $ 185
Markets Daily - Dec 6, 2016
Cooper Companies Inc (NYSE:COO) is expected to reveal its financials for the last quarter on 2016-12-08 according to the accessible information.
Cooper Companies Inc. (The) (COO) Moves Higher on Volume Spike for November 21
Equities.com - Nov 21, 2016
Cooper Companies Inc. (The) (COO) traded on unusually high volume on Nov. 21, as the stock gained 0.76% to close at $173.30.
Vernier Capital Partners Lp Lowers stake in Cooper Companies Inc (COO) - Trade Calls
Notable SEC Filing: Cooper Cos INC (COO) Valuation Rose While Rmb Capital ... - Chester News
The Cooper Companies, Inc. (NYSE:COO) Files An 8-K Acquires Wallace From ...
Market Exclusive - Nov 7, 2016
The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical has acquired Wallace, the in-vitro fertilization (IVF) segment of Smiths Medical, a division of Smiths Group plc, for a purchase price of approximately $168 million subject to ...
Cooper Companies Buys Smiths Medical's IVF segment Wallace for $168 mln - RTT News